News

The Chicago Sky have won two straight games, giving them a 2-4 record during the 2025 WNBA season. After losing their first three games by a combined 73 points, the Sky have responded by rising to ...
(RTTNews) - HUTCHMED (China) Limited (HCM) announced that results from the SACHI Phase III study represent a significant advancement in the treatment of EGFR mutation-positive NSCLC with MET ...
The former Iowa star dropped 11 points in just five minutes--a stretch that left even the WNBA in disbelief. "UNBELIEVABLE second quarter by @katemartin 勞" Thanks to Martin's heroics ...
HUTCHMED announced significant findings from the SACHI Phase III study, which investigated the combination of savolitinib and osimertinib in treating patients with locally advanced or metastatic ...
WNBA Fans in Disbelief Over Angel Reese's Pass originally appeared on Athlon Sports. During her first year in the WNBA, Angel Reese dished out 1.9 assists per game. Playmaking isn't really her ...
SCYNEXIS, Inc. (NASDAQ:SCYX) has officially restarted patient dosing in its Phase III MARIO trial for Brexafemme (ibrexafungerp) after the FDA lifted a nearly two-year clinical hold. The hold ...
"The Launch-HTN trial is the largest Phase III hypertension study with a novel drug. We tested lorundrostat in a large, diverse patient population recruited globally, and found that it has a good ...
Combo Attack III is one of the many Pictos you can acquire in Clair Obscur: Expedition 33, but where can you find it and what does it do? This page acts as a comprehensive breakdown of the Combo ...
The Minuteman III missile was unarmed when it launched from the Vandenberg Space Force Base in California, the military said. The missile traveled 15,000 miles per hour to a test site in the ...
See the launch of an unarmed Minuteman III ICBM from Vandenberg Space Force ... optical and telemetry data in its terminal phase, to help measure how well the missile performed.
Boehringer Ingelheim announced today detailed findings from the Phase III FIBRONEER™-IPF and FIBRONEER™-ILD trials. These studies evaluated nerandomilast, an investigational oral, preferential ...